Free Trial
The Market Does Not Wait. MarketBeat All Access Alerts for $149
Get the Alerts
Claim MarketBeat All Access Sale Promotion

Cigna Group (CI) Stock Forecast & Price Target

Cigna Group logo
$306.93 -8.95 (-2.83%)
Closing price 10/23/2026 03:59 PM Eastern
Extended Trading
$307.24 +0.31 (+0.10%)
As of 10/23/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cigna Group - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
0
Hold
8
Buy
15

Based on 23 Wall Street analysts who have issued ratings for Cigna Group in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 23 analysts, 8 have given a hold rating, and 15 have given a buy rating for CI.

Consensus Price Target

$338.24
10.20% Upside
According to the 23 analysts' twelve-month price targets for Cigna Group, the average price target is $338.24. The highest price target for CI is $400.00, while the lowest price target for CI is $290.00. The average price target represents a forecasted upside of 10.20% from the current price of $306.93.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for CI and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Cigna Group and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CI Analyst Ratings Over Time

TypeCurrent Forecast
10/25/25 to 10/25/26
1 Month Ago
9/25/25 to 9/25/26
3 Months Ago
7/27/25 to 7/27/26
1 Year Ago
10/25/24 to 10/25/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Strong Buy rating(s)
2 Strong Buy rating(s)
Buy
15 Buy rating(s)
15 Buy rating(s)
15 Buy rating(s)
15 Buy rating(s)
Hold
8 Hold rating(s)
8 Hold rating(s)
6 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$338.24$337.10$338.80$369.89
Forecasted Upside10.20% Upside23.83% Upside16.29% Upside22.55% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyModerate Buy

CI Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CI Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Cigna Group Stock vs. The Competition

TypeCigna GroupHealthcare CompaniesBroader Market
Consensus Rating Score
2.65
2.32
2.53
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside10.20% Upside1,400.11% Upside16.92% Upside
News Sentiment Rating
Positive News

See Recent CI News
Neutral News
Positive News
Report Date
0 Results
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
10/23/2026
Piper Sandler logo
Piper Sandler
2 of 5 stars
Jessica Tassan
Jessica Tassan
2 of 5 stars
Reiterated RatingOverweight
10/2/2026
Lance Wilkes
4 of 5 stars
Reiterated RatingOutperform
10/1/2026
UBS Group AG logo
UBS Group
4 of 5 stars
A.J. Rice
A.J. Rice
4 of 5 stars
Reiterated RatingBuy
10/1/2026Reiterated RatingOutperform$337.00+23.52%
9/9/2026 Initiated CoverageIn-Line$290.00+5.99%
8/27/2026 Reiterated RatingHold (C)
8/4/2026DowngradeBuy ➝ Hold$336.00 ➝ $307.00+8.76%
8/3/2026DowngradeStrong-Buy ➝ Outperform$350.00 ➝ $320.00+14.58%
7/31/2026 Set Target$362.00+26.90%
7/31/2026Boost TargetBuy$338.00 ➝ $361.00+25.54%
7/31/2026Boost TargetEqual Weight$305.00 ➝ $307.00+6.76%
7/31/2026Boost TargetEqual Weight$304.00 ➝ $310.00+7.80%
6/16/2026 Reiterated RatingOutperform$315.00+7.17%
6/8/2026Boost TargetOutperform$330.00 ➝ $340.00+18.07%
5/20/2026Boost TargetOverweight$355.00 ➝ $361.00+23.90%
5/20/2026DowngradeBuy ➝ Hold$303.00 ➝ $302.00+3.65%
5/4/2026 Boost TargetBuy$335.00 ➝ $340.00+20.08%
5/1/2026Boost TargetOverweight$325.00 ➝ $340.00+19.68%
2/17/2026Boost TargetBuy$320.00 ➝ $350.00+20.13%
2/9/2026Boost TargetBuy$333.00 ➝ $338.00+14.97%
2/6/2026 Boost TargetMarket Perform$270.00 ➝ $297.00+2.82%
1/5/2026 UpgradeStrong Sell ➝ Hold
11/4/2025Lower TargetOverweight$428.00 ➝ $375.00+42.26%
1/31/2025Lower TargetOutperform$400.00 ➝ $375.00+26.31%
1/31/2025Lower TargetOverweight$410.00 ➝ $380.00+28.89%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 03:52 PM ET.


Should I Buy Cigna Group Stock? CI Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, October 23, 2026. Please send any questions or comments about these Cigna Group pros and cons to contact@marketbeat.com.

Cigna Group
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in The Cigna Group:

  • The stock recently reached a new 52-week high of $316.27, with the current price trading at $306.93, indicating strong recent momentum and investor confidence in the company's performance.
  • Analysts maintain a consensus rating of Moderate Buy with a price target of $338.24, suggesting that the current market price of $306.93 offers potential upside of over 10% based on professional forecasts.
  • The company demonstrated strong financial performance in the most recent quarter, reporting earnings per share of $7.78 which exceeded the consensus estimate of $7.60, while revenue grew 6.7% year-over-year to $71.56 billion.
  • With a beta of 0.29, the stock exhibits significantly lower volatility than the broader market, making it a defensive investment option that may provide stability during periods of market uncertainty.
  • Institutional investors have shown increased confidence, with Robeco Institutional Asset Management B.V. increasing its holdings by 57.2% in the third quarter, signaling that large funds are accumulating shares.

Cigna Group
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in The Cigna Group for these reasons:

  • Insiders have been net sellers recently, with executives like Nicole Jones and Everett Neville selling thousands of shares in August and September 2026, which can signal a lack of confidence in near-term stock appreciation.
  • The company has a current ratio of 0.76, which is below 1.0, indicating that its current liabilities exceed its current assets, potentially raising concerns about short-term liquidity and debt management.
  • Short interest has been increasing, with shares shorted rising to 6,951,241 as of September 30, 2026, suggesting that a growing number of traders are betting against the stock's future performance.
  • The stock is trading near its 52-week high, which may limit the immediate upside potential for new investors compared to those who purchased at lower prices earlier in the year.
  • Some institutional investors, such as Integrated Advisors Network LLC, have significantly reduced their positions, selling 44.3% of their holdings in the third quarter, indicating divergent views on the stock's value.

CI Forecast - Frequently Asked Questions

According to the research reports of 23 Wall Street equities research analysts, the average twelve-month stock price forecast for Cigna Group is $338.24, with a high forecast of $400.00 and a low forecast of $290.00.

23 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cigna Group in the last year. There are currently 8 hold ratings and 15 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CI shares.

According to analysts, Cigna Group's stock has a predicted upside of 10.20% based on their 12-month stock forecasts.

Over the previous 90 days, Cigna Group's stock had 3 downgrades by analysts.

Analysts like Cigna Group more than other "healthcare" companies. The consensus rating for Cigna Group is Moderate Buy while the average consensus rating for "healthcare" companies is Hold. Learn more on how CI compares to other companies.


MarketBeat monitors more than a dozen sources for Cigna Group analyst ratings, with the most recent rating issued on 10/23/2026.
From Our Partners